Abstract P5-21-26: T-DM1 activity in metastatic HER2-positive breast cancer patients who have received prior trastuzumab and pertuzumab: NSABP B-005
Tiwari, SR, Sussman, T, Kota, K, Moore, HC, Montero, AJ, Budd, GT, Puhalha, S, Abraham, J
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article